Torthaí cuardaigh - Kevin W. Bailey

  • 1 - 13 toradh as 13 á dtaispeáint
Beachtaigh na torthaí
  1. 1
    Effects of Double Combinations of Amantadine, Oseltamivir, and Ribavirin on Influenza A (H5N1) Virus Infections in Cell Culture and in Mice

    Effects of Double Combinations of Amantadine, Oseltamivir, and Ribavirin on Influenza A (H5N1) Virus Infections in Cell Culture and in Mice de réir Donald F. Smee, Brett L. Hurst, Min-Hui Wong, Kevin W. Bailey, John D. Morrey

    Foilsithe / Cruthaithe 2009
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Effects of the Combination of Favipiravir (T-705) and Oseltamivir on Influenza A Virus Infections in Mice

    Effects of the Combination of Favipiravir (T-705) and Oseltamivir on Influenza A Virus Infections in Mice de réir Donald F. Smee, Brett L. Hurst, Min‐Hui Wong, Kevin W. Bailey, E. Bart Tarbet, John D. Morrey, Yousuke Furuta

    Foilsithe / Cruthaithe 2009
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    In Vivo Influenza Virus-Inhibitory Effects of the Cyclopentane Neuraminidase Inhibitor RWJ-270201

    In Vivo Influenza Virus-Inhibitory Effects of the Cyclopentane Neuraminidase Inhibitor RWJ-270201 de réir Robert W. Sidwell, Donald F. Smee, John H. Huffman, Dale L. Barnard, Kevin W. Bailey, John D. Morrey, Y.S. Babu

    Foilsithe / Cruthaithe 2001
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Favipiravir (T-705) protects against peracute Rift Valley fever virus infection and reduces delayed-onset neurologic disease observed with ribavirin treatment

    Favipiravir (T-705) protects against peracute Rift Valley fever virus infection and reduces delayed-onset neurologic disease observed with ribavirin treatment de réir Dionna Scharton, Kevin W. Bailey, Zachary Vest, Jonna B. Westover, Yohichi Kumaki, Arnaud J. Van Wettere, Yousuke Furuta, Brian B. Gowen

    Foilsithe / Cruthaithe 2014
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    In Vitro and In Vivo Activities of T-705 against Arenavirus and Bunyavirus Infections

    In Vitro and In Vivo Activities of T-705 against Arenavirus and Bunyavirus Infections de réir Brian B. Gowen, Min‐Hui Wong, Kie‐Hoon Jung, Andrew B. Sanders, Michelle Mendenhall, Kevin W. Bailey, Yousuke Furuta, Robert W. Sidwell

    Foilsithe / Cruthaithe 2007
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    Evaluation of Immunomodulators, Interferons and Known <i>in Vitro</i> SARS-CoV Inhibitors for Inhibition of SARS-Cov Replication in BALB/c Mice

    Evaluation of Immunomodulators, Interferons and Known <i>in Vitro</i> SARS-CoV Inhibitors for Inhibition of SARS-Cov Replication in BALB/c Mice de réir Dale L. Barnard, Craig W. Day, Kevin W. Bailey, Matthew Heiner, Robert A. Montgomery, Larry Lauridsen, Paul K.S. Chan, Robert W. Sidwell

    Foilsithe / Cruthaithe 2006
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 7
    Efficacy of Orally Administered T-705 on Lethal Avian Influenza A (H5N1) Virus Infections in Mice

    Efficacy of Orally Administered T-705 on Lethal Avian Influenza A (H5N1) Virus Infections in Mice de réir Robert W. Sidwell, Dale L. Barnard, Craig W. Day, Donald F. Smee, Kevin W. Bailey, Min‐Hui Wong, John D. Morrey, Yousuke Furuta

    Foilsithe / Cruthaithe 2006
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  8. 8
    Galidesivir limits Rift Valley fever virus infection and disease in Syrian golden hamsters

    Galidesivir limits Rift Valley fever virus infection and disease in Syrian golden hamsters de réir Jonna B. Westover, Amanda Mathis, Ray Taylor, Luci Wandersee, Kevin W. Bailey, Eric J. Sefing, Brady T. Hickerson, Kie‐Hoon Jung, William Sheridan, Brian B. Gowen

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  9. 9
    Treatment of Late Stage Disease in a Model of Arenaviral Hemorrhagic Fever: T-705 Efficacy and Reduced Toxicity Suggests an Alternative to Ribavirin

    Treatment of Late Stage Disease in a Model of Arenaviral Hemorrhagic Fever: T-705 Efficacy and Reduced Toxicity Suggests an Alternative to Ribavirin de réir Brian B. Gowen, Donald F. Smee, Min‐Hui Wong, Jeffery O. Hall, Kie‐Hoon Jung, Kevin W. Bailey, John R. Stevens, Yousuke Furuta, John D. Morrey

    Foilsithe / Cruthaithe 2008
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  10. 10
    Inhibition of severe acute respiratory syndrome coronavirus replication in a lethal SARS-CoV BALB/c mouse model by stinging nettle lectin, Urtica dioica agglutinin

    Inhibition of severe acute respiratory syndrome coronavirus replication in a lethal SARS-CoV BALB/c mouse model by stinging nettle lectin, Urtica dioica agglutinin de réir Yohichi Kumaki, Miles K. Wandersee, Aaron Smith, Yanchen Zhou, Graham Simmons, Nathan M. Nelson, Kevin W. Bailey, Zachary Vest, Joseph K.-K. Li, Paul K.S. Chan, Donald F. Smee, Dale L. Barnard

    Foilsithe / Cruthaithe 2011
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  11. 11
    Low-dose ribavirin potentiates the antiviral activity of favipiravir against hemorrhagic fever viruses

    Low-dose ribavirin potentiates the antiviral activity of favipiravir against hemorrhagic fever viruses de réir Jonna B. Westover, Eric J. Sefing, Kevin W. Bailey, Arnaud J. Van Wettere, Kie‐Hoon Jung, Ashley Dagley, Luci Wandersee, Brittney Downs, Donald F. Smee, Yousuke Furuta, Mike Bray, Brian B. Gowen

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  12. 12
    Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirin

    Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirin de réir Dale L. Barnard, Craig W. Day, Kevin W. Bailey, Matthew Heiner, Robert A. Montgomery, Larry Lauridsen, Scott Winslow, Justin D. Hoopes, Joseph K.-K. Li, Jong‐Dae Lee, Dennis A. Carson, Howard B. Cottam, Robert W. Sidwell

    Foilsithe / Cruthaithe 2006
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  13. 13
    Therapeutic alphavirus cross-reactive E1 human antibodies inhibit viral egress

    Therapeutic alphavirus cross-reactive E1 human antibodies inhibit viral egress de réir Lauren E. Williamson, Kristen M. Reeder, Kevin W. Bailey, Minh H. Tran, Vicky Roy, Mallorie E. Fouch, Nurgun Kose, Andrew Trivette, Rachel S. Nargi, Emma S. Winkler, Arthur S. Kim, Christopher Gainza, Jessica Rodríguez, Erica Armstrong, Rachel E. Sutton, Joseph X. Reidy, Robert H. Carnahan, W. Hayes McDonald, Clara T. Schoeder, William B. Klimstra, Edgar Davidson, Benjamin J. Doranz, Galit Alter, Jens Meiler, Kevin L. Schey, Justin G. Julander, Michael Diamond, James E. Crowe

    Foilsithe / Cruthaithe 2021
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: